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     Transfer factor (s) - are small molecules, that transfer the ability to recognize pathogens (bacterial or viral) cells of the 
immune system, never exposed to this pathogen. The function of the transfer factor is to convert non-sensitized naive lymphocytes 
in highly specific cells that meet standard way to antigenic stimulation. As soon as the lymphocytes are similar conversion, they 
are after exposure to the antigen begin to express all the properties that are typical of naturally sensitized cells, including skin 
reactivity in vivo, the transformation of lymphocytes, clonal proliferation and the production of effector molecules, such as a MIF. 
Immunological studies showed that TF does not function as antigen or superantigen. It is also shown that TF is not able to induce 
the formation of antibodies in the recipient, even if the antigen is the cellular response (Lawrence, Pappenheimer, 1956; Rapaport 
et al., 1960). No less important was the fact that the results in the expression of TF in the recipient of an identical set of donor 
immunological markers, ie we can talk about moving to the donor for a long time a specific immunologic memory (Jensen et al., 
1962). The high specificity of immunological TF confirmed in experiments to transplant skin grafts. 
  Isolated from the crude extract of leukocytes active fraction contains a short  TF for the polypeptide chains  44-60 of 
amino acid residues , which are variable (N-terminal) and conservative (C-terminal) part of (Kirkpatrick, 1993). The C-terminal 
domain contains a highly conserved decapeptide (LeuLeuTyrAlaGlnAspLeu / ValGluAspAsn) (Kirkpatrick, 2000). This is 
decapeptide sequence is found in all the purified transfer factor, but not in the primary structure of a large number of analyzed 
antigens. Like immunoglobulins, TF immunologically definitely linked to the intact antigen molecules (Kirkpatrick et al., 1985), 
but recovery or alkylation does not lead to dissociation of TF on the light and heavy chains. T lymphocyte receptors do not bind 
antigens intact molecules, as do the TF, although immune responses, which are transferred to recipients by TF mediated by T 
lymphocytes. It is believed that the transfer factor molecule after connecting with the corresponding antigen of the intact molecule 
can interact with the variable region of alpha and / or beta-chain T-cell receptors (Dwyer, 1996). Development of methods for 
production and purification of individual specific TF against specific pathogens offers great opportunities for the development and 
production of new means of molecular immunotherapy for patients with specific defects in cellular immunity. In addition, because 
the TF has no species specificity, drugs derived from lymphocytes of immunized animals are free to be used to treat people 
(Dwyer, 1996; Grinevich et al., 2008). In this case, the main target of the TF are effector mechanisms of cellular immune 
responses, it does not address the humoral immune system. Provides literature and own results of the TF as immunocorrector. 
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